Article contents
Use of high-dose depot neuroleptics
Published online by Cambridge University Press: 02 January 2018
Abstract
To identify and reduce the number of patients receiving depot neuroleptics above the British National Formulary maximum. The medical records were scrutinised and individual consultants were informed of the results.
For the team involved in this audit there was a significant reduction in the prescription of high-dose depot medication, but this did not generalise to other teams.
Different teams should repeat the audit and a new depot card has been developed.
- Type
- Original papers
- Information
- Creative Commons
- This is an Open Access article, distributed under the terms of the Creative Commons Attribution (CC-BY) license (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted re-use, distribution, and reproduction in any medium, provided the original work is properly cited.
- Copyright
- Copyright © 1999 The Royal College of Psychiatrists
References
- 1
- Cited by
eLetters
No eLetters have been published for this article.